Therapeutic effects and safety of resveratrol for lung cancer: an updated preclinical systematic review and meta-analysis

医学 荟萃分析 肺癌 科克伦图书馆 白藜芦醇 癌症 内科学 肿瘤科 药理学
作者
Xiang Xiao,Xuanyu Wu,Wenyuan Li,Fengming You,Jing Guo
出处
期刊:Frontiers in Nutrition [Frontiers Media]
卷期号:12: 1644538-1644538 被引量:9
标识
DOI:10.3389/fnut.2025.1644538
摘要

Background: Lung cancer (LC) is the most common cause of cancer-related death worldwide, while there are limited treatment methods. Resveratrol (RESV), a natural food-derived compound, has attracted attention around the world for its anti-LC effects. However, little is known about the efficacy and safety of RESV for LC. Purpose: This study aimed to provide preclinical evidence for the efficacy and safety of RESV for LC, and to find the optimal dose and duration. Methods: studies of RESV against LC, published before 24 July 2024, were retrieved from PubMed, Embase, Web of Science, and Cochrane Library. The CAMARADES checklist was used to assess study quality. Primary outcomes were tumor volume and tumor weight. Secondary outcomes included body weight, lung metastases number, and the apoptotic cell proportion. Statistical analysis was performed using RevMan 5.3 and Stata 16.0. Dose-duration-effect model was conducted to determine the optimal dose and duration, and the toxicology of RESV was predicted through the ProTox 3.0 platform. Results: A total of 23 studies involving 425 animals were included. The methodological quality of included studies was medium-to-low. RESV significantly reduced tumor volume, tumor weight, and lung metastases number, and increased apoptotic cell proportion, while having no effect on body weight. High heterogeneity was observed, and subgroup analysis suggested that the heterogeneity was partly attributed to the dose of RESV. The optimal dose and duration of RESV were 30-100 mg/kg and 25-28 days, respectively. The median lethal dose of RESV was 1,560 mg/kg. Conclusion: . However, the lower research quality and high heterogeneity call for more high-quality preclinical studies to be conducted. Before achieving clinical translational research on RESV, the problem of low bioavailability of RESV needs to be solved.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
小水滴完成签到,获得积分10
1秒前
翰林路发布了新的文献求助10
1秒前
QUIET发布了新的文献求助10
1秒前
sssugar完成签到,获得积分10
2秒前
yaoenhao发布了新的文献求助10
2秒前
超帅从彤完成签到,获得积分10
2秒前
是寄竹吖发布了新的文献求助10
3秒前
lee完成签到 ,获得积分10
4秒前
betty孙发布了新的文献求助10
4秒前
4秒前
4秒前
刘谦发布了新的文献求助10
5秒前
英勇皮卡丘完成签到,获得积分10
6秒前
谨慎问玉完成签到 ,获得积分10
6秒前
7秒前
表弟慢热手的应助被LI采纳,获得30
8秒前
斯文的乐天完成签到,获得积分10
9秒前
miaoli0116完成签到,获得积分10
9秒前
9秒前
lirui_nicely完成签到,获得积分10
10秒前
10秒前
虚幻的靖儿完成签到 ,获得积分10
10秒前
11秒前
言默发布了新的文献求助10
11秒前
lx发布了新的文献求助10
12秒前
谨慎的雁菡完成签到 ,获得积分10
12秒前
隐形的小蚂蚁完成签到,获得积分10
12秒前
young完成签到 ,获得积分10
13秒前
13秒前
funnyzpc完成签到,获得积分10
13秒前
13秒前
14秒前
JhXia发布了新的文献求助10
14秒前
小蘑菇的应助被兜兜想哒哒采纳,获得10
14秒前
思源的应助被好天气采纳,获得10
14秒前
蓝调小丸子完成签到 ,获得积分10
14秒前
李瑞发布了新的文献求助20
15秒前
江河日山发布了新的文献求助20
16秒前
yaoenhao完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186480
求助须知:如何正确求助?哪些是违规求助? 9574861
关于积分的说明 21838499
捐赠科研通 7784154
什么是DOI,文献DOI怎么找? 3434775
关于科研通互助平台的介绍 2559164
邀请新用户注册赠送积分活动 2481565